X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-09-08 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $35.63 | -2,388 | 144,032 | -2% | -$85,084 | ||||||
2023-08-11 | MRTX | Boxer Capital, LLC | See remarks | P - Purchase | $27.80 | +1,258,973 | 6,672,789 | +23% | +$34,999,449 | ||||||
2023-08-11 | MRTX | Boxer Capital, LLC | See remarks | P - Purchase | $27.80 | +1,258,973 | 6,672,789 | +23% | +$34,999,449 | ||||||
2023-08-11 | MRTX | Hasnain Faheem | Dir | P - Purchase | $27.80 | +10,791 | 25,841 | +72% | +$299,990 | ||||||
2023-06-02 | MRTX | Stelzer Laurie | CFO | S - Sale | $37.06 | -4,647 | 80,015 | -5% | -$172,218 | ||||||
2023-05-24 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $45.29 | -619 | 124,123 | 0% | -$28,035 | ||||||
2023-01-18 | MRTX | Cherrington Julie M | Dir | S - Sale | $44.66 | -2,546 | 0 | -100% | -$113,704 | ||||||
2023-01-17 | MRTX | Meek David D. | CEO | S - Sale | $42.38 | -3,179 | 61,792 | -5% | -$134,715 | ||||||
2023-01-17 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $42.38 | -2,245 | 97,878 | -2% | -$95,142 | ||||||
2023-01-17 | MRTX | Hickey Benjamin | EVP, Chief Commercial Officer | S - Sale | $42.38 | -1,566 | 47,223 | -3% | -$66,366 | ||||||
2023-01-09 | MRTX | Hickey Benjamin | EVP, Chief Commercial Officer | S - Sale | $45.37 | -2,088 | 48,789 | -4% | -$94,733 | ||||||
2023-01-04 | MRTX | Baum Charles M | Pres,Founder,Head of R, D | S - Sale | $46.60 | -3,648 | 168,777 | -2% | -$169,997 | ||||||
2023-01-04 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $46.60 | -1,949 | 100,123 | -2% | -$90,823 | ||||||
2022-12-21 | MRTX | Baum Charles M | Pres,Founder,Head of R, D | S - Sale | $40.42 | -9,092 | 172,425 | -5% | -$367,469 | ||||||
2022-12-21 | MRTX | Hickey Benjamin | EVP, Chief Commercial Officer | S - Sale | $40.41 | -3,248 | 50,877 | -6% | -$131,266 | ||||||
2022-12-21 | MRTX | Meek David D. | CEO | S - Sale | $40.41 | -4,616 | 64,971 | -7% | -$186,552 | ||||||
2022-12-16 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $43.00 | -2,410 | 102,072 | -2% | -$103,624 | ||||||
2022-12-02 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $90.19 | -1,726 | 104,482 | -2% | -$155,667 | ||||||
| D | 2022-11-28 | MRTX | Baum Charles M | Pres,Founder,Head of R, D | S - Sale+OE | $100.00 | -69,256 | 127,899 | -35% | -$6,925,600 | |||||
| D | 2022-08-12 | MRTX | Carter Bruce L A | Dir | S - Sale+OE | $85.49 | -10,000 | 6,021 | -62% | -$854,899 | |||||
2022-05-23 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $63.54 | -624 | 86,804 | -1% | -$39,649 | ||||||
2022-01-19 | MRTX | Cherrington Julie M | Dir | S - Sale | $116.07 | -1,475 | 2,546 | -37% | -$171,203 | ||||||
| D | 2022-01-18 | MRTX | Reed Vickie S | SVP, Chief Accounting Officer | S - Sale+OE | $120.48 | -533 | 15,369 | -3% | -$64,217 | |||||
| D | 2022-01-18 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale+OE | $120.51 | -627 | 87,428 | -1% | -$75,558 | |||||
| D | 2022-01-18 | MRTX | Baum Charles M | Pres,Founder,Head of R, D | S - Sale+OE | $120.48 | -2,517 | 127,899 | -2% | -$303,253 | |||||
| D | 2022-01-18 | MRTX | Hickey Benjamin | EVP, Chief Commercial Officer | S - Sale+OE | $120.48 | -627 | 34,976 | -2% | -$75,543 | |||||
2022-01-07 | MRTX | Hickey Benjamin | EVP, Chief Commercial Officer | S - Sale | $135.94 | -1,964 | 24,848 | -7% | -$266,984 | ||||||
2022-01-07 | MRTX | Reed Vickie S | SVP, Chief Accounting Officer | S - Sale | $135.94 | -345 | 10,525 | -3% | -$46,900 | ||||||
2022-01-04 | MRTX | Baum Charles M | Pres,Founder,Head of R, D | S - Sale | $147.75 | -4,114 | 101,170 | -4% | -$607,855 | ||||||
2022-01-04 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $147.72 | -1,442 | 77,300 | -2% | -$213,017 | ||||||
2022-01-04 | MRTX | Reed Vickie S | SVP, Chief Accounting Officer | S - Sale | $147.74 | -758 | 10,870 | -7% | -$111,987 | ||||||
2021-12-06 | MRTX | Christensen Jamie | EVP, Chief Scientific Officer | S - Sale | $130.79 | -1,201 | 59,505 | -2% | -$157,078 | ||||||
| D | 2021-12-03 | MRTX | Baum Charles M | Pres, Head of R, D | S - Sale+OE | $133.20 | -47,204 | 112,714 | -30% | -$6,287,687 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |